123 related articles for article (PubMed ID: 36786815)
21. [Value of combined detection of GP73 and alpha-fetoprotein in diagonosis of hepatocellular carcinoma].
Wu QP; Xie FY; Meng QL; Mu YY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Apr; 26(2):148-9. PubMed ID: 23002561
[TBL] [Abstract][Full Text] [Related]
22. [Establishment and preliminary application of serum Golgi protein 73 based noninvasive diagnostic model for compensated stage hepatitis B cirrhosis].
Zhai XW; Liu SH; Yao MJ; Qian XJ; Wen XJ; Xu Q; Zhao JM; Lu FM
Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):47-52. PubMed ID: 32023699
[No Abstract] [Full Text] [Related]
23. Serum Golgi protein 73 is a marker comparable to APRI for diagnosing significant fibrosis in children with liver disease.
Liu L; Wang J; Feng J; Yao M; Hao C; You Y; Yan Y; Gong J; Lu Y; Xie X; Zhang M; Chen L; Li T; Lu F; Wang JS
Sci Rep; 2018 Nov; 8(1):16730. PubMed ID: 30425268
[TBL] [Abstract][Full Text] [Related]
24. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Morota K; Nakagawa M; Sekiya R; Hemken PM; Sokoll LJ; Elliott D; Chan DW; Dowell BL
Clin Chem Lab Med; 2011 Apr; 49(4):711-8. PubMed ID: 21231906
[TBL] [Abstract][Full Text] [Related]
25. Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.
Liu T; Yao M; Liu S; Wang L; Wang L; Hou J; Ma X; Jia J; Zhao J; Zhuang H; Lu F
Oncotarget; 2017 Mar; 8(10):16498-16506. PubMed ID: 28157705
[TBL] [Abstract][Full Text] [Related]
26. The predictive value of Golgi protein 73 in differentiating benign from malignant liver tumors.
Bröker ME; Ijzermans JN; Witjes CD; van Vuuren HJ; de Man RA
PLoS One; 2014; 9(7):e100187. PubMed ID: 25033446
[TBL] [Abstract][Full Text] [Related]
27. Assessment of serum Golgi protein 73 as a biomarker for the diagnosis of significant fibrosis in patients with chronic HBV infection.
Cao Z; Li Z; Wang Y; Liu Y; Mo R; Ren P; Chen L; Lu J; Li H; Zhuang Y; Liu Y; Wang X; Zhao G; Tang W; Xiang X; Wang H; Cai W; Liu L; Zhu C; Bao S; Xie Q
J Viral Hepat; 2017 Nov; 24 Suppl 1():57-65. PubMed ID: 29082644
[TBL] [Abstract][Full Text] [Related]
28. Glypican-3, Vascular Endothelial Growth Factor and Golgi Protein-73 for Differentiation between Liver Cirrhosis and Hepatocellular Carcinoma.
Mamdouh S; Soliman A; Khorshed F; Saber M
Asian Pac J Cancer Prev; 2023 Feb; 24(2):497-507. PubMed ID: 36853298
[TBL] [Abstract][Full Text] [Related]
29. Exploring the Diagnostic Potential of Serum Golgi Protein 73 for Hepatic Necroinflammation and Fibrosis in Chronic HCV Infection with Different Stages of Liver Injuries.
Qian X; Zheng S; Wang L; Yao M; Guan G; Wen X; Zhang L; Xu Q; Chen X; Zhao J; Duan Z; Lu F
Dis Markers; 2019; 2019():3862024. PubMed ID: 31636735
[TBL] [Abstract][Full Text] [Related]
30. Predictive value of serum Golgi protein 73 for prominent hepatic necroinflammation in chronic HBV infection.
Xu Z; Shen J; Pan X; Wei M; Liu L; Wei K; Liu L; Yang H; Huang J
J Med Virol; 2018 Jun; 90(6):1053-1062. PubMed ID: 29424455
[TBL] [Abstract][Full Text] [Related]
31. Possible roles of Golgi protein-73 in liver diseases.
Liu MY; Huang L; Wu JF; Zhang HB; Ai WB; Zhang RT
Ann Hepatol; 2022; 27(5):100720. PubMed ID: 35577277
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Golgi Protein 73 (GP73) as a Potential Biomarkers for Hepatocellular Carcinoma.
Shaker MK; Attia FM; Hassan AA; Shedid MM; Aboelmagd MA; Faisal AS
Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776730
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of alpha-fetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels.
Xu WJ; Guo BL; Han YG; Shi L; Ma WS
Tumour Biol; 2014 Dec; 35(12):12069-74. PubMed ID: 25209179
[TBL] [Abstract][Full Text] [Related]
34. Serum gp73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infection.
Qiao Y; Chen J; Li X; Wei H; Xiao F; Chang L; Zhang R; Hao X; Wei H
Clin Biochem; 2014 Nov; 47(16-17):216-22. PubMed ID: 25168922
[TBL] [Abstract][Full Text] [Related]
35. Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.
Wang Y; Yang H; Xu H; Lu X; Sang X; Zhong S; Huang J; Mao Y
J Gastroenterol Hepatol; 2014 Mar; 29(3):597-602. PubMed ID: 24236824
[TBL] [Abstract][Full Text] [Related]
36. [Retrospective observation of dynamic levels of serum Golgi protein 73 in patients prior to the onset of liver cancer].
Chen JG; Lu WZ; Zhu YR; Zhang YH; Lu JH; Chen TY
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Aug; 47(8):731-5. PubMed ID: 24246080
[TBL] [Abstract][Full Text] [Related]
37. GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population.
Hu JS; Wu DW; Liang S; Miao XY
Med Oncol; 2010 Jun; 27(2):339-45. PubMed ID: 19399652
[TBL] [Abstract][Full Text] [Related]
38. Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma.
Hou SC; Xiao MB; Ni RZ; Ni WK; Jiang F; Li XY; Lu CH; Chen BY
Oncol Lett; 2013 Oct; 6(4):1152-1158. PubMed ID: 24137480
[TBL] [Abstract][Full Text] [Related]
39. Golgi protein 73(GP73), a useful serum marker in liver diseases.
Liu X; Wan X; Li Z; Lin C; Zhan Y; Lu X
Clin Chem Lab Med; 2011 Aug; 49(8):1311-1316. PubMed ID: 21663469
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of fucosylated GP73 in the differential diagnosis of hepatocellular carcinoma.
Zhao Y; Zhang L; Huo L; Pei L; Li Q; Li H; Jin L
Int J Biol Markers; 2018 Nov; 33(4):439-446. PubMed ID: 30238841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]